Ximedica

Antibiotic Susceptibility Testing

Converting existing technologies to meet critical needs in infectious disease testing

Background:

LifeScale® AST ​
Affinity Biosensors

Need:

Adapt Affinity’s unique particle metrology technology for the microbiology market to address rapid diagnosis and selection of appropriate antibiotic therapy. ​

Solution:

Ximedica provided a solution to the automation of the assay workflow through our AsysTek™ robotics engine along with deep experience in system architecture, while Affinity supplied its unique MEMS technology and focus on the microbiology applications.​

Result:

Ximedica and Affinity produced fully functional clinical trial units under strictly regimented ISO-13485 design controls. The new LifeScale platform offers several key benefits over optical density measurement of microbes. These include ultra-high resolution of mass, detection of growth at lower concentrations, and elimination of measurement anomalies associated with microbe labels or surface binding.​

The latest in MedTech & Diagnostics straight to your inbox

Stay Informed

At Ximedica, our people define who we are.

More About Our People

Luke Hagan

Luke Hagan

Senior Research & Development Engineer

Richard Piatt

Richard Piatt

Senior Design Engineer

Farzanah Ausaluth

Farzanah Ausaluth

Production Supervisor

Matt Loftus

Matt Loftus

Director of Business Development

Talia Serrecchia

Talia Serrecchia

Clinical and Human Research Affairs Specialist

Michelle Wu

Michelle Wu

VP, Quality